San Jose, CA 95129
working hours
24/7 Hours
+1 669 264 1656

Healthcare & Life Sciences
 Mar 09, 2020 |   MDHE51D3470J
Biologics Outsourcing, By Product (Antibody, monoclonal antibody, Bi-specific Antibody, Antibody Drug Conjugates, Recombinant Protein, Vaccines), By Type ( Kits & Reagents, Instruments, Source, Microbial, Mammalian), By Application (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, Stem Cell Research) and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026
  • Report Description
  • Table of contents

Globally, biologic drug manufacturing is increasing and most of the pharma companies are focusing on biologics due to rising incidences of chronic diseases, increasing spending on R&D, and increasing the aging population. However, the biologic industry is facing major challenges like a high capital requirement, lack of skilled people, high technical requirement and regulatory issues. Therefore, pharma companies are looking for outsourcing options for biology drug development which fuel the demand for the biologics outsourcing market. Broadly, the biologics outsourcing industry consists of instruments and kits manufacturing. In addition to this, the increasing usage of antibodies to treat chronic diseases like asthma and diabetes increase the investment in research and development activities which increase the demand for biologics outsourcing. Globally, the biologics outsourcing market is growing at double-digit CAGR and increasing its presence in the healthcare sector.

The report offers detailed coverage of Biologics Outsourcing market and industry trends to provide a comprehensive view of the market. The Biologics Outsourcing research report includes market estimation & forecasting, demand & supply analysis, price trends, company market share of the leading players in Biologics Outsourcing market. The report splits the market based on various segments. The Biologics Outsourcing market report also describes the main players and how they are strengthening their position in the market with the latest innovations, strategic acquisitions, partnership and collaboration. It also provides the financial analysis, SWOT analysis, company overview and portfolio analysis of the leading players in the Biologics Outsourcing market. 

  • Boehringer Ingelheim GmbH
  • Catalent Inc.
  • GenScript
  • Innovent Biologics Inc.
  • Syngene
  • Shanghai Medicilon inc.
  • GL Biochem Corporation Ltd.
  • GVK Biosciences Private Limited
  • Horizon Discovery Group plc. Innovent Biologics Inc.
  • Selexis SA
  • Lonza
  • Abzena Plc
  • Adimab LLC

Biologics Outsourcing Segments

The Biologics Outsourcing market is segmented as below



  • Antibody
  • monoclonal antibody
  • Bi-specific Antibody
  • Antibody Drug Conjugates
  • Recombinant Protein
  • Vaccines


  • Kits & Reagents
  • Instruments
  • Source
  • Microbial
  • Mammalian


  • Vaccine & Therapeutics Development
  • Blood & Blood Related Products Testing
  • Cellular and Gene Therapy
  • Tissue and Tissue Related Products Testing
  • Stem Cell Research

The Biologics Outsourcing market report brings market data at one point to understand the Biologics Outsourcing market growth trends, market size, and future scenario of the market. This analysis will help clients to plan their expansion, investment, merger acquisition strategy and bring the improvement. All the data of Biologics Outsourcing market is demonstrated in such a way that the end-user can leverage the analyzed data. The analysis includes all segment and sub-segment analysis and their scope, growth rate, market opportunities and challenges. 

The qualitative analysis of Biologics Outsourcing market report includes competitive landscape, key growth, and restraining factors. In addition to this, the PESTEL, Porter's Five, and Value chain analysis enables users to understand how the micro and macro-economic factors have influenced the Biologics Outsourcing market.  The global analysis of Biologics Outsourcing market report allows users to understand the competitive factors in the market, which help them to take strategic business decisions for sustainable growth. 

In Biologics Outsourcing market report the top-down and bottom-up approach has applied to estimate the market value. In the top-down and bottom-up approach, the report considered primary and secondary research. In the primary research, multiple interviews were conducted with CEOs, CFOs, and product managers of the leading players. The interviews also include the subject matter expert, investors, and end-user interviews. Secondary research includes company annual reports, press releases, whitepapers, market players’ association news portal, government portal, and journals. 

Galaxy Market Research

Galaxy Market Research is a one-stop market research, advisory, consulting and, industry analysis reports platform. The reports' library providing business data and intelligence information on thousands of micro as well as high growth markets with global as well as regional coverage.